In Florida, Dyadic reports a net loss of $1.5 million for the quarter ended March 31, 2013 compared to a a net loss of $781,000 in Q1 2012. Dyadic’s cash and cash equivalents increased 3% to $4.1 million at quarter end, when compared to the cash balance of $4.0 million as of December 31, 2012. […]
In Florida, Dyadic announced today that Danai Brooks will join the Company as Executive Vice President and Chief Operating Officer in June. Brooks joins Dyadic from J.P. Morgan where he served as a Vice President in the firm’s Investment Bank – previously, he served in senior operational, engineering and manufacturing positions with Dell Inc., Mars […]
In Florida, Dyadic announced today that it has been upgraded by OTC Markets to “Current Information” which is the highest trading tier on the OTC Pink marketplace. The disclosures required for this upgrade have been posted on the OTC Markets website (www.otcmarkets.com) under Dyadic’s ticker symbol, “DYAI.” Dyadic’s President and CEO, Mark Emalfarb, stated, “The confidence […]
In the Netherlands, Dyadic has commenced commercialization of enzymes developed by the EU-funded DISCO project coordinated by VTT Technical Research Centre of Finland. The project’s results include lignin-tolerant enzymes and enzyme cocktails for processing spruce, straw, corn cob and wheat bran. The raw materials studied in the project were spruce, straw, corn cob and wheat […]
Biofuels Digest has released the next wave of its 5-Minute Guides – a “news you can use” digest on the leading companies in biofuels. Each 5-Minute Guide provides a company description, 3 top milestones for 2010-12 and projected for 2012-14, description of the business model; plus project info (location, feedstocks, product set, processing technology, capacity, […]
Company description: Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries. Address: 140 Intracoastal Pointe Drive Suite 404 Jupiter, Florida 33477 Year founded: […]
In Florida, Dyadic International announced that it has been issued U.S. Patent No. 8,304,212 entitled “Methods and compositions for degradation of lignocellulosic material” by the USPTO. The inventions embodied by this patent relate to methods and compositions for using enzyme mixtures to convert plant biomass into fermentable sugars for the production of useful products. The […]
In Florida, global biotechnology company Dyadic International, Inc. announced the results of its cooperation with SEKAB E-Technology to verify effective enzymes for the degradation of cellulose into fermentable sugars, following the recent completion of the 4-year EU-funded DISCO research project. During the project, SEKAB successfully verified Dyadic’s biofuels enzyme, AlternaFuel® CMAX™ at its ethanol demonstration […]
In Florida, the United States Patent and Trademark Office issued Dyadic International, Inc. the U.S. Patent No. 8,268,585 entitled, “Transformation System in the Field of Filamentous Fungal Hosts”. The patent covers methods of developing, programming and growing improved strains of fungus that make up Dyadic’s C1 platform technology. It also covers the construction and use […]
In The Netherlands, Dyadic International announced they are a participant in the HealthBread Project, a new multidisciplinary research program that has been awarded approximately €1M from the European Community’s Seventh Framework Programme. The HealthBread Project is a two year research program whose objective is to develop whole grain and white breads with improved nutritional value, […]
